Munich - Delayed Quote EUR
Viking Therapeutics Inc (1VT.MU)
22.46
+0.09
+(0.42%)
As of 8:08:07 AM GMT+2. Market Open.
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 1VT.MU | -- | -- | -- | -- |
| S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/17/2025 |
| Initiated | Goldman Sachs: Neutral | 4/8/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/26/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/11/2025 |
| Initiated | Scotiabank: Sector Outperform | 2/13/2025 |
| Initiated | Citigroup: Neutral | 2/7/2025 |
Related Tickers
430.DU Terns Pharmaceuticals Inc
2.4800
-3.88%
1OT.F Ovid Therapeutics Inc.
0.2260
+15.31%
RXK3.F SELLAS Life Sciences Group, Inc.
1.1500
-2.21%
EXOZ eXoZymes, Inc.
13.53
+14.76%
AVBP ArriVent BioPharma, Inc.
21.08
+3.94%
RAPP Rapport Therapeutics, Inc.
11.38
-1.47%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
19.56
+0.82%
GYRE Gyre Therapeutics, Inc.
9.19
+6.37%
BCAX Bicara Therapeutics Inc.
15.51
+12.23%
MBX MBX Biosciences, Inc.
8.99
+4.05%